ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
shionogi
The Global Project Leader at Shionogi provides strategic and operational leadership for rare disease clinical development programs across the full lifecycle, driving integrated program strategy, execution, and decision-making within a global matrixed governance model. The role partners with cross‑functional and headquarters stakeholders to shape recommendations, ensure governance quality, and deliver program objectives aligned with portfolio priorities and long‑term patient impact.
Headquarters
Florham Park, New Jersey, United States
Company Size
501-1000 employees
Founded
2001
Shionogi Inc. is a discovery-based pharmaceutical company dedicated to developing, partnering, and commercializing medicines to address serious unmet medical needs. It advances a diverse pipeline through internal R&D, clinical trials, and collaborations, including programs for rare diseases (e.g., Fragile X syndrome) and other therapeutic areas. The company emphasizes transparency, sustainability, patient advocacy, and support for investigators through grants and expanded-access policies. Leveraging global resources and partnerships, Shionogi works to bring novel therapies to patients and healthcare stakeholders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for shionogi.
120% above the average for this role
Vice President, Head of US Medical Affairs, Rare Disease
Ipsen
Program Lead, Development - Rare Disease
Alnylam Pharmaceuticals
Director, Medical Affairs, Rare Diseases - Europe
Regeneron Pharmaceuticals
Associate Medical Director, Rare Disease - Friedreichs Ataxia (US Medical Affairs)
biogen
Medical Manager, Rare Disease, Gulf
AstraZeneca
Global Regulatory Lead - Rare Diseases
Denali Therapeutics